申请人:Abbott Laboratories
公开号:US05597832A1
公开(公告)日:1997-01-28
A tetracyclic compound of the formula: ##STR1## wherein A and the atoms to which it is attached and the optional double bond represent a mono- or di-heterocyclic ring selected from: ##STR2## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and X are specifically defined, which compounds are useful in the treatment of dopamine-related neurological, psychological and cardiovascular disorders as well as in the treatment of substance abuse and other addictive behavior disorders, cognitive impairment and attention deficit disorder.
一种四环化合物的化学式:##STR1## 其中A及其连接的原子和可选的双键代表从中选择的单环或双环杂环环,该环选自:##STR2## 其中R.sup.1、R.sup.2、R.sup.3、R.sup.4和X具体定义,这些化合物在治疗与多巴胺相关的神经、心理和心血管疾病以及物质滥用和其他成瘾行为障碍、认知损害和注意力缺陷障碍方面具有用处。